Lipitor Generics: Judge Questions Mylan's Right To Sue Over Ranbaxy Marketing Exclusivity

Questions during an April 28 court hearing suggest Mylan Pharmaceuticals Inc. may have a difficult time persuading a federal judge that it has standing, at this time, to force an FDA determination on generic marketing exclusivity rights for Pfizer's Lipitor